Publications

Filter by year

Filter by type

Filter by year

2025

The Global Research on the Impact of Dermatological Diseases (GRIDD) in Germany

N. da Silva Burger, R. Pattinson, N. Trialonis-Suthakharan, J. Austin, A. Fitzgerald, C. Bundy & M. Augustin 

Poster presented at the conference of the German Dermatological Association (DDG), Berlin, Germany.

 

Responsiveness and Minimally Important Change of the Patient-Reported Impact of Dermatological Diseases (PRIDD) questionnaire

N. da Silva Burger, R. Pattinson, A. Fitzgerald, N. Trialonis-Suthakharan, J. Austin, C. Bundy, M. Augustin

Poster presented at the 34th EADV Congress, Paris, France

Workshop: Stigmatisierung bei Hautpatient/-innen

R. Sommer

Workshop presented at the Fachsymposium Psychosomatik und
Psychotherapie, Gießen, Germany

A Psychometric Evaluation of the Cumulative Life Course Impairment Questionnaire (DermCLCI-r) Among Patients with Chronic Skin Disease

C.F.Z. Stuhlmann, M. Augustin, R. Sommer

Poster presented at the 34th EADV Congress, Paris, France

Cumulative Life Course Impairment (CLCI): Messung der kumulierenden Lebensbelastungen bei Patienten mit Psoriasis in der Routineversorgung mit einem validierten Instrument

M. Augustin, R. Matthews, R. Warren, C. Braren-von Stülpnagel, A. Fatehi, M. Rudnik & R. Sommer

Poster presented at the conference of the German Dermatological Association (DDG), Berlin, Germany.

 

Erfassung der Lebensqualität bei Säuglingen und Kleinkindern mit Hauterkrankungen – Validierung des deutschen InToDermQoL-Fragebogens

J. Traxler, M. Augustin, R. Sommer, S. Hoffmann, R. Fölster-Holst, M. Baumeister, P. Staubach, N. da Silva Burger & H. Ott

Poster presented at the conference of the German Dermatological Association (DDG), Berlin, Germany.

Benefits and Satisfaction with Apremilast Treatment in Patients with Psoriasis Affecting the Genital Area: Secondary Analysis of the APPRECIATE Study

N. da Silva Burger, K.V. Tran, M. Typou, R. Sommer, D. Neasham, M. Cordey & M. Augustin

Plaque-type psoriasis affects the genital area in 7–42% of patients, and can impose significant quality of life (QoL) impairments. In this case, systemic treatment is recommended regardless of the affected body surface area. This real-world study compared treatment effects and patient-reported outcomes (PROs) between patients with and without genital lesions, undergoing apremilast treatment for 6 ± 1 months. Secondary analyses were conducted using data from the observational, retrospective, cross-sectional APPRECIATE study. 

PMID:
39969771
DOI:
https://doi.org/10.1007/s13555-025-01360-y

Effectiveness of a Self-Compassion Programme to Reduce Self-Stigma in Chronic Skin Diseases: the HautKompass RCT

J. Traxler, C. F. Z. Stuhlmann, N. da Silva Burger, C. Stierle, V. Djamei, A. Darzina, M. Rudnik & R. Sommer

Oral presentation presented at the European Health Psychology Society (EHPS), Groningen, the Netherlands

Skin Love – Entwicklung und Anwendung einer Methodik zur Charakterisierung des emotionalen Verhältnisses mit der Haut

M. Augustin, J. Augustin, J. Gutermuth & R. Sommer 

Poster presented at the conference of the German Dermatological Association (DDG), Berlin, Germany.

 

Communication and Treatment Planning in Reproductive-Age Psoriasis Patients Undergoing Immunomodulatory Therapy – A Survey in the German Psoriasis Registry PsoBest

B. Stephan, C. Sorbe, B. Zyriax, J. Schmittinger, M. Augustin, R. Sommer, N. da Silva Burger, Sticherling, von Kiedrowski, Weyergraf, L. Kühl

Poster presented at the 34th EADV Congress, Paris, France

<< < 1 2 3 4 > >>